Geneva, Oct. 21 -- International Clinical Trials Registry received information related to the study (NCT07215325) titled 'Got Doxy- 'Flipping the Script' on STI PEP' on Oct. 3.
Study Type: Interventional
Study Design:
Allocation: Randomized. Intervention model: Parallel Assignment. Primary purpose: Basic Science. Masking: None (Open Label).
Primary Sponsor: Emory University
Condition:
Sexually Transmitted Infections (STI)
Intervention:
Drug: Doxycycline monohydrate 200 mg
Recruitment Status: Not recruiting
Phase: Phase 4
Date of First Enrollment: November 2025
Target Sample Size: 200
Countries of Recruitment:
United States
To know more, visit https://clinicaltrials.gov/study/NCT07215325
Published by HT Digital Content S...